SEC Form 4 · accession 0001209191-15-008395
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Green
Director
Period of report
Jan 29, 2015
Accepted (ET)
Feb 2, 2015 · 6:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 29, 2015 | F | 19,512 | $5.25 | D | 950,713 | D | |
| Common StockF2 | Jan 30, 2015 | F | 2,698 | $5.25 | D | 948,015 | D | |
| Common Stock | holding | — | — | — | 300,000 | I | David Green 2013 Annuity Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (e) 874,723 shares of common stock held by the Reporting Person.
- F2Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (e) 872,025 shares of common stock held by the Reporting Person.
Remarks
The reported sales were made pursuant to the terms of a 10b5-1 trading plan. This form has been signed under power of attorney.